Skip to content

Andrew Silverman, MD, MHS

NPI 1275169260ActiveIndividual· Ophthalmology, Neuro-ophthalmology· New York, NY

Ophthalmology, Neuro-ophthalmology (MD, MHS) in New York, New York, trained at Yale University School of Medicine (class of 2020). Enrolled in Medicare as practitioner - ophthalmology. Biomarin Pharmaceutical Inc. reported $2,737 in payments in 2025, mostly consulting fees.

Overview

NPI1275169260
StatusActive
Entity typeIndividual
CredentialMD, MHS
Sole proprietorNo
NPI issuedMar 21, 2020
Last updated in NPPESSep 23, 2025
Certified by providerSep 23, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Ophthalmology, Neuro-ophthalmology Primary207WX0109X335525NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Ophthalmology (NY)

Medicare sources and data years

Education and affiliations

Medical schoolYale University School of Medicine
Graduation year2020
Medicare specialtyOphthalmology

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$2,737 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Biomarin Pharmaceutical Inc.$2,7372

What the 2025 payments were for

  • Consulting Fee$2,737 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Ophthalmology, Neuro-ophthalmology providers in New York

All Ophthalmology, Neuro-ophthalmology providers in New York